Prominent publications by Anna Thorisdottir

KOL Index score: 11410

BACKGROUND: The prevalence and severity of lipodystrophy syndrome with long-term therapy for HIV-1 infection that includes a protease inhibitor is unknown. We studied the natural course of the syndrome to develop diagnostic criteria and identifying markers that predict its severity.

METHODS: We assessed 113 patients who were receiving HIV-1 protease inhibitors (mean 21 months) and 45 HIV-1-infected patients (28 with follow-up) never treated with a protease inhibitor. Lipodystrophy was ...

Also Ranks for: Diabetes Mellitus |  physical examination |  protease inhibitor |  prevalence severity |  therapy hiv1

Key People For Prevalence Severity

Top KOLs in the world
Ronald * *******
mental disorders united states major depression
Douglas * *******
observational studies consort statement randomised trials
Neil * ******
new zealand global burden lung cancer
David ***** ********
lung function international study air pollution
Aubrey *******
dental caries oral health periodontal disease
Christopher * * ******
global burden life expectancy united states

Anna Thorisdottir:Expert Impact

Concepts for whichAnna Thorisdottirhas direct influence:Prevalence severity,  Protease inhibitor,  Lipodystrophy severity,  Inhibitor therapy,  Severity lipodystrophy,  Inhibitor lipodystrophy,  Hiv1 infection,  Hiv1 protease inhibitors.

Anna Thorisdottir:KOL impact

Concepts related to the work of other authors for whichfor which Anna Thorisdottir has influence:Antiretroviral therapy,  Hiv infection,  Insulin resistance,  Protease inhibitors,  Human immunodeficiency virus,  Infected patients,  Highly active.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

HIV Medicine Unit and Centre for Immunology, St Vincent's Hospital, Sydney, NSW 2010, Australia